The upheaval at the Food and Drug Administration appears to be taking a toll on the pharmaceutical industry, according to a ...
At a major cancer conference, Merck rolled out some showstoppers — data on drugs on which its business future may depend.
The WHO announced that the last Ebola patient in Congo’s latest outbreak was discharged over the weekend and no new cases ...
BERLIN — In June, Amgen reported that an experimental drug had hit the main goal of a gastric cancer study, improving overall ...
From STAT’s Adam Feuerstein: Let’s start with Replimune, which said this morning the Food and Drug Administration will review ...
Patients with an aggressive form of breast cancer will likely have new treatment options after AstraZeneca and Gilead ...
AI tools designed to make health care more efficient are ubiquitous, though many remain piecemeal and siloed, as researchers ...
This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here. Guys, last week was so great. I got to catch up with STAT pals in Boston and even some of YOU at the STAT ...
Noubar Afeyan tells the STAT Summit that political moves to replace facts with opinions won't stop with mRNA vaccines. "It’s ...
Safeguarding biodiversity is not simply an environmental concern but a foundational element of preventive and clinical care.
Mark Sendak was getting tired of seeing the toil of so many colleagues go to waste. At Duke University, he was part of a team ...
In a case that was billed as profits versus patients, India’s Supreme Court dismissed a petition in which Roche sought to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback